Douleur Therapeutics Inc.
Douleur Therapeutics Inc. is a clinical stage biopharmaceutical company focused on advancing DT-001, novel small molecule treatment for neuropathic pain.
NanoAxis LLC is a leading nanomedicine and technology company that was founded by Dr. Chakravarthy in Buffalo, NY in 2008.
The company utilizes a unique nanomaterials based platform for development of new nanomedical applications across both diagnostic and therapeutic domains. NanoAxis works with various academic and industrial partners, and current areas of biological interest and product platforms include the creation of new medical devices, gene therapy applications, and targeted drug delivery systems based on nanotechnology.
The company’s current lead candidate is a new vaccine alternative and treatment strategy for seasonal and pandemic influenza, which employs biomimetic nanoparticles for targeted gene therapy.